Mark J. Levin is Director at MILLENNIUM PHARMACEUTICALS INC (MLNM). They have made 2 open-market trades across 2 companies since 2007, most recently 2021-11-10.
CIK 0001180428
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.3M since 2019, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RVMD | 7,024,031 | $1.3B |
| MYOK | 885,104 | $199.1M |
| RLAY | 9,970,454 | $162.5M |
| NRIX | 5,383,333 | $131.3M |
| SAGE | 4,742,916 | $41.2M |
| NTGN | 9,399,999 | $28.9M |
| CTMX | 8,670,351 | $19.8M |
| FMI | 120,577 | $16.5M |
| FULC | 3,962,202 |
Shares reported on the most recent Form 4, priced at the 2021-11-12 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FULC | BUY | 2019-07-22 | 2019-07-22 | $16.00 | $1.3M | +14.0% | -12.1% | -65.5% |
| BPMC | SELL | 2017-03-16 | 2017-03-20 | $40.98 | $1.4M | -4.4% | +12.8% | -1.7% |
| MLNM | SELL · 10b5-1 | 2008-01-09 | 2008-01-10 | $15.06 | $29K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2008-01-09 | 2008-01-10 | $15.12 | $122K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2008-01-02 | 2008-01-03 | $16.17 | $120K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2008-01-02 | 2008-01-03 | $16.27 | $42K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-12-26 | 2007-12-27 | $15.58 | $156K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-12-19 | 2007-12-21 | $15.06 | $17K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-12-19 | 2007-12-21 | $14.91 | $133K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-12-12 | 2007-12-13 | $15.54 | $14K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-12-12 | 2007-12-13 | $15.70 | $143K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-12-05 | 2007-12-06 | $15.25 | $17K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-12-05 | 2007-12-06 | $15.18 | $135K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-11-28 | 2007-11-29 | $15.19 | $12K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-11-28 | 2007-11-29 | $15.24 | $140K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-11-21 | 2007-11-26 | $14.06 | $135K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-11-21 | 2007-11-26 | $14.15 | $6K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-11-14 | 2007-11-15 | $13.97 | $134K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-11-14 | 2007-11-15 | $14.00 | $6K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-11-07 | 2007-11-08 | $13.05 | $38K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-11-07 | 2007-11-08 | $13.19 | $94K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-10-03 | 2007-10-04 | $10.26 | $103K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-09-26 | 2007-09-27 | $10.15 | $102K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-09-19 | 2007-09-20 | $10.56 | $105K | N/A | N/A | N/A |
| MLNM | SELL · 10b5-1 | 2007-09-12 | 2007-09-13 | $10.00 | $100K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| $14.5M |
| BPMC | 111,244 | $14.4M |
| VYGR | 6,391,176 | $12.1M |
| JNCE | 2,697,829 | $5.1M |
| MLNM | 2,264,224 | — |
| Total | $1.9B |